News
Search EMA's news announcements
Resultat (3827)
Vyjuvek expected to bring substantial therapeutic benefits and improve quality of life for patients with ultra-rare genetic skin disorder
NewsHumanMedicines
Positive opinion for extension of indication brings disease-modifying treatment to all cystic fibrosis patients with modulator responsive mutations
NewsHumanMedicines
Eco-Management and Audit Scheme (EMAS) certificate is a mark of environmental excellence in the EU
NewsCorporate
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
NewsVeterinaryMedicinesVaccines
PRAC carried out its broad range of responsibilities for managing the risks associated with medicine use
NewsHumanMedicinesPharmacovigilanceReferrals
Clinical Trials Information System now supports submission, assessment and oversight of all trials in the EU
NewsHumanClinical trials
EMA opinion for ivermectin and albendazole supports global efforts to eliminate widespread infections
NewsHumanMedicinesMedicines for use outside the EU
The review of Vimkunya was expedited because of public health interest
NewsHumanMedicines
Eight new medicines recommended for approval; one positive opinion for a medicine intended for use outside the EU
NewsHumanMedicinesMedicines for use outside the EU
The extensive use of azole fungicides (azoles), particularly in some agricultural and horticultural practices, can increase the risk of Aspergillus fungi developing resistance to essential antifungal treatments. This significant finding is highlighted in a report by the five EU health and environment agencies, with support from the European...
NewsHumanVeterinaryMedicines